Von Willebrand Factor Antigen Predicts Response to Double Dose of Aspirin and Clopidogrel by PFA-100 in Patients Undergoing Primary Angioplasty for St Elevation Myocardial Infarction
Von Willebrand factor (VWF) is an emerging risk factor in acute coronary syndromes. Platelet Function Analyzer (PFA-100) with Collagen/Epinephrine (CEPI) is sensitive to functional alterations of VWF and also identifies patients with high on-treatment platelet reactivity (HPR). The objective of this...
Saved in:
| Main Authors: | Jacopo Gianetti, Maria Serena Parri, Francesca Della Pina, Federica Marchi, Endrin Koni, Alberto De Caterina, Stefano Maffei, Sergio Berti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1155/2013/313492 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of clopidogrel responsiveness using the Platelet Function Analyzer-200 (PFA-200) in dogs
by: Joon-Ho Shin, et al.
Published: (2025-07-01) -
Endobronchial biopsies in patients receiving clopidogrel and aspirin treatment
by: Bilal Rabahoğlu, et al.
Published: (2025-07-01) -
Platelet Reactivity and Response to Aspirin and Clopidogrel in Patients with Platelet Count Disorders
by: Wiktor Kuliczkowski, et al.
Published: (2021-01-01) -
Prevalence of Aspirin and Clopidogrel Resistance in Patients with Recurrent Ischaemic Cerebrovascular Disease
by: Niyata Hananta Karunawan, et al.
Published: (2021-12-01) -
Comparison of effectiveness of aspirin, clopidogrel and cilostazol monotherapy treatment in ischaemic stroke
by: Endarwati Tuti, et al.
Published: (2025-01-01)